How genetic differences affect nalbuphine pain relief after abdominal or pelvic surgery
Official title: Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management
Run by Ziauddin University · NCT06996561 · Data updated 2026-11-12
We will test whether genetic differences change how well nalbuphine relieves pain after abdominal or pelvic surgery in adults.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 263 (estimated) |
| Sponsor | Ziauddin University Academic / other |
| Locations | 1 site (Karachi, Sindh) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | January 1, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | April 15, 2026 |
| Trial ID | NCT06996561 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70, ASA class 1–3, undergoing open abdomino-pelvic surgeries lasting 2–4 hours who can provide informed consent are the intended participants.
✕Probably not a fit
Patients with procedures longer than 4 hours, on excluded interacting medications, pregnant or breastfeeding, with opioid allergy or dependency, or receiving epidural/nerve-block analgesia are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional Phase 2/3 study will collect a preoperative blood sample and use next-generation whole exome sequencing to identify genetic variants in adults undergoing open abdomino-pelvic surgeries. All participants receive nalbuphine as part of standard intraoperative and postoperative analgesia, and their pain responses and clinical outcomes will be measured. Investigators will correlate genetic variants with nalbuphine analgesic efficacy to identify markers of opioid sensitivity or resistance within the Pakistani population. The goal is to generate molecular data that could support more personalized and safer opioid use in this setting.
Why it matters
Potential benefit: If successful, the findings could help tailor opioid choice and dosing to patients' genetics, improving pain control and safety after surgery.
How similar studies have gone: Prior clinical work shows nalbuphine, tramadol, and morphine have comparable analgesic effects and opioid pharmacogenetics affects response, but nalbuphine-specific genetic evidence—particularly in Pakistani populations—is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All adult men or women 2. Age 18 to 70 years 3. ASA criteria 1,2 and 3 4. Abdomino-pelvic surgeries (open hernia repair, appendicectomy, open cholecystectomy, laparotomy, hysterectomy, cystectomy) lasting 2-4 hours Exclusion Criteria: 1. Surgical procedure duration lasting more than 4 hours 2. Patients taking anti fungal fluconazole, anticoagulant (Warfarin or Clopidogrel) SNRI (Amitryptalline), Rifampicin or Buprenorphine, 3. History of hypersensitivity or allergy to opioids, 4. Pregnant or breastfeeding mothers, 5. History of narcotic dependency, addiction, and withdrawal 6. Patients experiencing any adverse side effects or complications during surgical procedure requiring intensive care admission 7. Refusing to participate in the study 8. Surgical procedures utilizing other modes of intraoperative analgesia e.g epidural analgesia or nerve blocks
Where it's running
-
Ziauddin University
Karachi, Sindh, Pakistan Recruiting
Study contacts
- Study coordinator: Asma Abdus Salam, FCPS, MCPS, MBBS
- Email: asma.salam.azhar@gmail.com
- Phone: +923002122264
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effectiveness of M-TAPA nerve block for pain relief after laparoscopic hysterectomy
This study tests whether the M-TAPA nerve block before surgery can reduce opioid use and pain after laparoscopic hysterectomy compared with standard pain care.
-
Stanford program to advance robotic surgery for children and adolescents
This program will try the da Vinci Xi surgical robot in children and adolescents (ages 6–21, ≥15 kg) to see if it is safe and works well for procedures like sleeve gastrectomy, cholecystectomy, splenectomy, hysterectomy, and operations for endometriosis.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
Palatal Shield Technique to Reduce Pain and Improve Healing After Free Gingival Graft
This randomized trial tests whether a collagen sponge with a protective palatal shield made of flowable resin helps reduce pain and improve healing after free gingival graft harvest.
-
Perfusion Index to Measure Postoperative Pain in Kids After Adenotonsillectomy
This study tests whether the perfusion index can reliably reflect pain levels in children aged 1–12 after adenotonsillectomy, comparing standard care with an added glossopharyngeal nerve block.
-
Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy
This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.